Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropifexor in Primary Bile Acid Diarrhea
NCT02713243Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tropifexor in primary bile acid diarrhea (PBAD), sponsored by Novartis. Started Jan 2016; status: completed.
02
Drugs
tropifexor
03
Conditions
primary bile acid diarrhea (PBAD)
Beyond the preview
Go deeper on NCT02713243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713243.